TTF‐1 is expressed in 75–80% of lung adenocarcinoma (LADC), a non‐small‐cell lung cancer (NSCLC) subtype, and is a marker of the terminal respiratory unit (TRU) subtype (Yatabe et al., 2002). Here, TTF1 is linked to lung adenocarcinoma.